JP Morgan Maintains Chemours at Neutral, Lowers Price Target to $14
Nov 9, 2026
JP Morgan maintains a Neutral rating on Chemours Co., lowering its price target to $14 from $15. The adjustment implies a 9.8% upside from the November 6 closing price.
Show all 156 updates